Dr. Jonathan Miller 6/10/23 Dr. Jonathan Miller 6/10/23

Risks of high cholesterol and benefits of statins misrepresented by unacceptable scientific behavior

The emphasis on relative risk coupled with insufficient disclosure of absolute risk in the reporting of randomized controlled trial outcomes has led healthcare providers and the public to overestimate concerns about high cholesterol and to be misled as to the magnitude of the benefits of cholesterol-lowering therapy.

6/19/17 6/19/17

Insulin resistance increases cardiovascular disease

9/17/15 9/17/15

Oxidized LDL promotes atherosclerosis

Research recently published in Science Signaling elucidates one of the mechanisms by which oxidized LDL promotes atherosclerosis

10/8/14 10/8/14

Nuts reduce inflammation and all-cause mortality

In the absence of allergy, the evidence supports the consumption of nuts as wholesome foods with anti-inflammatory and metabolic benefits, exactly what paleo diets intend to accomplish.

10/20/13 10/20/13

Metabolic health status and aging determined by inflammation, not weight

Metabolic health is not reliably determined by weight or BMI (body mass index). Lean individuals can suffer from cardiovascular and other diseases involving metabolism, and evidence has been mounting that supports the notion of a subtype of obesity that is metabolically healthy. Inflammation can determine metabolic health in both obese and non-obese populations.